Competition Patents Seed Funding 
Startup Professionals Musings
OCTOBER 10, 2012
A while back I received a discouraging note from an entrepreneur with a patent and a medical software application who couldn’t find a dime of investment, and was grousing that seed funding just wasn’t available anymore. Fundraising is indeed brutally tough at all stages, and the seed funding is the hardest to find.
Both Sides of the Table
OCTOBER 30, 2014
Did anybody hold patents that would prevent us from using this technology? I seldom hire patent attorneys during due diligence but this was too important. Meredith Perry came up with the idea for uBeam while still in college at University of Pennsylvania and like many great inventors won her school’s business plan competition.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Startup Professionals Musings
MARCH 10, 2021
A while back I received a discouraging note from an entrepreneur with a patent and a medical software application who couldn’t find a dime of investment, and was grousing that seed funding just wasn’t available anymore. Fundraising is indeed brutally tough at all stages, and seed funding is the hardest to find.
Startup Professionals Musings
AUGUST 9, 2011
A while back I received a discouraging note from an entrepreneur with a patent and a medical software application who couldn’t find a dime of investment, and was grousing that seed funding just wasn’t available anymore. Fundraising is indeed brutally tough at all stages, and the seed funding is the hardest to find.
Startup Professionals Musings
NOVEMBER 17, 2013
A while back I received a discouraging note from an entrepreneur with a patent and a medical software application who couldn’t find a dime of investment, and was grousing that seed funding just wasn’t available anymore. Fundraising is indeed brutally tough at all stages, and the seed funding is the hardest to find.
Startup Professionals Musings
JULY 3, 2010
Yesterday I received a discouraging note from an entrepreneur with a patent and a medical software application who couldn’t find a dime of investment, and was grousing that seed funding just wasn’t available anymore. Fundraising is indeed brutally tough at all stages, and the seed funding is the hardest to find.
Xconomy
JUNE 3, 2016
Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5
Expert insights. Personalized for you.
Let's personalize your content